BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2025 7:04:46 AM | Browse: 8 | Download: 61
 |
Received |
|
2025-02-04 19:31 |
|
Peer-Review Started |
|
2025-02-04 19:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-03-21 07:59 |
|
Revised |
|
2025-03-31 15:06 |
|
Second Decision |
|
2025-04-22 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-04-22 10:45 |
|
Articles in Press |
|
2025-04-22 10:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-14 02:36 |
|
Publish the Manuscript Online |
|
2025-05-27 07:04 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sahana Shetty, Renuka Suvarna, Vanessa Ambrose Fistus, Shivam Modi and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, MD, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, Manchester, Manchester M15 6BH, Please enter the state or province, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Cardiovascular disease; Cardiovascular events; Insulin resistance; Metabolic dysfunction-associated fatty liver disease; Type 2 diabetes mellitus. |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease (MAFLD) and type 2 diabetes mellitus (T2DM) are independent risk factors for the development of cardiovascular disease (CVD) with an exaggerated risk of cardiovascular events (CVE) when both diseases co-exist. A systematic review of fourteen studies with 370013 participants showed that the risk of CVE in T2DM was higher in the MAFLD group when compared to the non-MAFLD group [odds ratios (OR): 1.28] with follow up duration ranging between 5-6 years. The prevalence of CVD was higher (OR: 1.47) in T2DM with MAFLD when compared to T2DM without MAFLD. In conclusion, presence of MAFLD in T2DM increased the risk of CVE and CVD as compared to T2DM without MAFLD. |
| Publish Date |
2025-05-27 07:04 |
| Citation |
<p>Shetty S, Suvarna R, Ambrose Fistus V, Modi S, Pappachan JM. Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis. <i>World J Hepatol</i> 2025; 17(5): 105706</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i5/105706.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i5.105706 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
